9 Benzylmorphine;

R Codeine methylbromide;

Desomorphine;

Myrophine;-Oxide;Morphine-N-Oxide;

Myrophine;

Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation, which contains any quantity of the following hallucinogenic substances, or which contains any of its salts, isomers, and salts of isomers, whenever the existence of such salts, isomers, only,and thesalts termof "isomer"isomers includesis possible within the optical,specific position,chemical anddesignation geometric(for isomers):purposespurposes of this subdivision Alpha-ethyltryptamineonly, (somethe tradeterm or"isomer" otherincludes names:the optical, position, and geometric isomers):

Alpha-ethyltryptamine (some trade or other names:

Diethyltryptamine;

of 13 2,5-dimethoxy-4-ethylamphetamine (DOET);

of 13 3-Hexyl-1-hydroxy-7,8,9,10-tetrahydro-6,6,9-trimethyl-6H-dibenzo [b,d] pyran;

of 13 4-Ethylmethcathinone (other name:

E Beta-keto-methylbenzodioxolylpentanamine (other names:

N Alpha-methylamino-valerophenone (other name:

R 3,4-Dimethylmethcathinone (other name:

4-methyl-alpha-pyrrolidinopropiophenone (other name:

MPPP);

25-I, O 25I-NBOMe, 2C-I-NBOMe);

L Methoxetamine (other names:

Lof 13 4-Fluoroamphetamine (other name:

E 2-(2,5-Dimethoxy-4-methylphenyl)ethanamine (other name:

D 2-[4-(Ethylthio)-2,5-dimethoxyphenyl]ethanamine (other name:

2-(2,5-Dimethoxyphenyl)ethanamine (other name:

2C-H);

S 4-chloro-2,5-dimethoxy-N-[(2-methoxyphenyl)methyl]-benzeneethanamine (other names:

7 2C-C-NBOMe, 25C-NBOMe, 25C);

9 4-bromo-2,5-dimethoxy-N-[(2-methoxyphenyl)methyl]-benzeneethanamine (other names:

R 2C-B-NBOMe, 25B-NBOMe, 25B);

Alpha-pyrrolidinobutiophenone (other name:

alpha-PBP);

1-(1,3-benzodioxol-5-yl)-2-(ethylamino)-1-pentanone (other name:

N-ethylpentylone);

3-methoxy PCP);pentylone);PCP);

1-(1,3-benzodioxol-5-yl)-2-(dimethylamino)-1-pentan(other1-(1,3-benzodioxol-5-yl)-2-(dimethylamino)-1-pentanone (other names:

3,4-tetramethylene-alpha-pyrrolidinovalerophenone (other name:

TH-PVP);

Allylescaline);VP);Allylescaline);

6-ethyl-6-nor-lysergic acid diethylamide (other name:

ETH-LAD);

AL-LAD);;AL-LAD);

of 13 2-(methylamino)-2-phenyl-cyclohexanone (other name:

of 13 5-methoxy-N,N-dibutyltryptamine (other name:

of 13 Aminorex (some trade or other names;

E Cathinone (some trade or other names:

R Ethylamphetamine;

Fenethylline;piperidin-2-yl)acetateEthyl phenyl(piperidin-2-yl)acetate (other name:

OFenethylline; Methcathinone (some other names:

Methcathinone (some other names:

L alpha-(methylamino)-propiophenone;

L methylcathinone;

E N-Benzylpiperazine (some other names:

N, N-alpha-trimethyl-benzeneethanamine, N, D N-alpha-trimethylphenethylamine) N,N-alpha-trimethyl-benzeneethanamine, N,N-alpha-trimethylphenethylamine);

Isopropyl-2-phenyl-2-(2-piperidinyl)acetateMethyl 2-(4-fluorophenyl)-2-(2-piperidinyl)acetate (other name:

Isopropylphenidate);lphenidate);4-fluoromethylphenidate);

of 13 Isopropyl-2-phenyl-2-(2-piperidinyl)acetate (other name:

Isopropylphenidate);

Any substance that contains one or more cannabimimetic agents or that contains their saltS,salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isome7sisomers is possible within the specific chemical designation, and any preparation, mixture, or substance c9ntaining,containing, or mixed or infused with, any detectable amount of one or more cannabimimetic agents.

R a.

2-(3-hydroxycyclohexyl)phenol with substitution at the 5-position of the phenolic ring by alkyl or alk3-(1-naphthoyl)indolealkenyl, or 1H-indol-3-yl-(1-naphthyl)methane with substitution at the nitrogen atom of the indole ring, whether or not further substituted on the indolecyclohexyl ring to any extent, whether or not substituted on the naphthoyl or naphthyl ring to any extent;

3-(1-naphthoyl)indole or 1H-indol-3-yl-(1-naphthyl)methane with substitution at the nitrogen atom of the indole ring, whether or not further substituted on the indole ring to any extent, whether or not substituted on the naphthoyl or naphthyl ring to any extent;

3-phenylacetylindole or 3-benzoylindole with substitution at the nitrogen atom of the indole ring, whether or not further substituted in the indole ring to any extent, whether or not substituted on the phenyl ring to any extent;

N-(adamantyl)-indole-3-carboxamide with substitution at the nitrogen atom of the indole ring, whether or not further substituted on the indole ring to any extent, whether or not substituted on the adamantyl ring to any extent;

anddand on the indole ring to any extent, whether or not substituted on the N-(adamantyl)-indazole-3-carboxamide with substitution at a nitrogen atom of the indazole ring, whether or not further substituted on the indazole ring to any extent, whether or not substituted on the adamantyl ring to any extent.

1-butyl-3-(1-naphthoyl)indole (other name:

JWH-073);

of 13 1-[2-(4-morpholinyl)ethyl]-3-(1-naphthoyl)indole (other name:

Pravadoline (4-methoxyphenyl)-[2-methyl-1-(2-(4-morpholinyl)ethyl)indoll]methanone(4-methoxyphenyl)-[2-methyl-1-(2-(4-morpholinyl)ethyl)indol-3-y l]methanone (other name:

of 13 N-adamantyl-1-fluoropentylindole-3-carboxamide (other name:

N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)indazole-3-carboxa(otherN-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)indazole-3-carboxamide (other name:

N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)indazole-3-carboxam ide N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)indazole-3-carbo(otherN-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)indazole-3-carboxamid(other names:

N-(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)-1-[(4-fluorophenyl)methyl]-1H-indaz3-carboxamideN-(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)-1-[(4-fluorophenyl)methyl]-1H-indazole- N-(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)-1-[(4-fluorophenyl)methyl]-1H-indazole-3-carb(othere3-carboxamide N-(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)-1-[(4-fluorophenyl)methyl]-1H-indazole-3-carboxamid(other name:

Methyl 2-[1-[(4-fluorophenyl)methyl]-1H-indazole-3-carboxamido]-3methylbutanoate2-[1-[(4-fluorophenyl)methyl]-1H-indazole-3-carboxamido]-3,3-dmethylbutanoate (other name:

Methyl 2-({1-[(4-fluorophenyl)methyl]-1H-indazole-3-carbonyl}amino)-3-methylbuean(other2-({1-[(4-fluorophenyl)methyl]-1H-indazole-3-carbonyl}amino)-3-methylbutanoae (other names:

of 13 Naphthalen-1-yl 1-pentyl-1H-indazole-3-carboxylate (other name:

E AB-CHMICA);

N Quinolin-8-yl 1-(4-fluorobenzyl)-1H-indole-3-carboxylate (other name:

R Methyl N-[1-(cyclohexylmethyl)-1H-indole-3-carbonyl]valinate (other name:

N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(5-fluoropentyl)indazole-3-carboxamid e N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(5-fluoropentyl)indazole-3-carboxamide (other name:

O 5-fluoro-ADB-PINACA);

L 1-(4-cyanobutyl)-N-(1-methyl-1-phenylethyl)-1H-indazole-3-carboxamide (other name:

L Methyl 2-[1-(5-fluoropentyl)-1H-indole-3-carboxamido]-3,3-dimethylbutanoate (other name:

E 5-Fluoro-MDMB-PICA) names:

Ethyl 2-({1-[(4-fluorophenyl)methyl]-1H-indazole-3-carbonyl}amino)-3-methylbutanoat e Ethyl D 2-({1-[(4-fluorophenyl)methyl]-1H-indazole-3-carbonyl}amino)-3-methylbutanoate (other name:

4-fluoro-MDMB-BUTINACA);utyl)-1H-indazole-3-carboxamido]-3,3-dimethylbutanoateMethyl 2-[1-4-fluorobutyl)-1H-indazole-3-carboxamido]-3,3-dimethylbutanoate (other name:

4-fluoro-MDMB-BUTINACA);

S MDMB-4en-PINACA);

7 Methyl 2-({1-[(4-fluorophenyl)methyl]-1H-indole-3-carbonyl}amino)-3-methylbutanoate (other n9mes:names:

of 13 MMB-FUBICA, AMB-FUBICA);

R Methyl 2-[1-(4-penten-1-yl)-1H-indole-3-carboxamido]-3-methylbutanoate (other names:

5-fluoro-MPP-PICA);luoropentyl)-1H-indole-3-carboxamido]-3-phenylpropanoateMethyl 2-[1-(5-fluoropentyl)-1H-indole-3-carboxamido]-3-phenylpropanoate (other name:

5-fluoro-MPP-PICA);

5-fluoro-EMB-PINACA,Ethyl-2-[1-(5-fluoropentyl)-1H-indazole-3-carboxamido]-3-methylbutanoate 5F-AEB);)-1H-indazole-3-carboxamido]-3-methylbutanoate (other names:

5-fluoro-EMB-PINACA, 5F-AEB);

Methyl 2-(1-(cyclohexylmethyl)-1H-indole-3-carboxamido)-3,3-dimethylbuta(other2-(1-(cyclohexylmethyl)-1H-indole-3-carboxamido)-3,3-dimethylbutanoate (other names:

ADB-4en-PINACA).3-dimethyl-1-oxobutan-2-yl)-1-(pent-4-enyl)indazole-3-carboxamideN-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(pent-4-enyl)indazole-3-carboxamide (other name:

ADB-4en-PINACA).

Opium extracts;

of 13 Granulated opium;

of 13 2.

of 13 Phenmetrazine and its salts;

Any substance which contains any quantity of methamphetamine, including its salts, isomers, Endand salts of isomers;

N Lisdexamfetamine, its salts, isomers, and salts of its isomers.

R 4.

Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a depressant effect on the central nervous system, including its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation:

L Amobarbital;

L Secobarbital;

E Pentobarbital;

D 5.

Dronabinol ((-)-delta-9-trans tetrahydrocannabinol) in an oral solution in a drug product approved for marketing by the U.S.

Food and Drug Administration.ol)Administration. in an oral solution in a drug product approved for 6.

6.

S Phenylacetone.

7 b.

9 1-phenylcyclohexylamine;

R 1-piperidinocyclohexanecarbonitrile (other name:

The§ controlled54.1-3452. substances listed in this section are included in Schedule IV unless specifically excepted or listed in another schedule:

Schedule IV.

The controlled substances listed in this section are included in Schedule IV unless specifically of 13 excepted or listed in another schedule:

Bromazepam;;Brexanolone;

Bromazepam;

Cloxazolam;;Clotiazepam;

Cloxazolam;

Flurazepam;

of 13 Haloxazolam;

of 13 Fenfluramine;

Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, of 13 or preparation which contains any quantity of the following substances, including their salts:

E Eluxadoline (including its optical isomers and its salts, isomers, and salts of isomers);

NPentazocine. 6.

The6. Board may except by regulation any compound, mixture, or preparation containing any depressant substance listed in subdivision 1 from the application of all or any part of this chapter if the compound, mixture, or preparation contains one or more active medicinal ingredients not having O depressant effect on the central nervous system, and if the admixtures are included therein in combinations, quantity, proportion, or concentration that vitiate the potential for abuse of the substances which have a depressant effect on the central nervous system.

LThe §Board 54.1-3454.may except by regulation any compound, mixture, or preparation containing any depressant substance listed in subdivision 1 from the application of all or any part of this chapter if the compound, mixture, or preparation contains one or more active medicinal ingredients not having a depressant effect on the central nervous system, and if the admixtures are included therein in combinations, quantity, proportion, or concentration that vitiate the potential for abuse of the substances which have a depressant effect on the central nervous system.

§ 54.1-3454.

The controlled substances listed in this section are included in Schedule V:

Not more than 100 milligrams of ethylmorphine, or any of its salts, per 100 milliliters or per 100 grams;

more than 100 milligrams of ethylmorphine, or any of its salts, per 100 milliliters or pSr 100 Not more than 2.5 milligrams of diphenoxylate and not less than 25 micrograms of atropine sulfate per dosage unit;

5 Not more than 100 milligrams of opium per 100 milliliters or per 100 grams;

E Not more than 0.5 milligrams of difenoxin and not less than 25 micrograms of atropine sulfate per dosage unit.

The Board may except by regulation any compound, mixture, or preparation containing any suchdepressant substancessubstance solisted exceptedin maysubdivision be1 dispensedfrom pursuantthe toapplication §of 54.1-3416.allall or any part of this chapter and 2.such substances so excepted may be dispensed pursuant to § 54.1-3416.

2.

Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation that contains any quantity of the following substances having a depressant effect on the cenBrivaracetamof ((2S)-2-[(4R)-2-oxo-4-propylpyrrolidin-1-yl]13 butanamide)central (alsonervous referredsystem, toincluding asits BRV;salts:

Brivaracetam ((2S)-2-[(4R)-2-oxo-4-propylpyrrolidin-1-yl] butanamide) (also referred to as BRV;

commitment.2.

PursuantThat to § 30-19.1:4 of the Codeprovisions of Virginia,this theact estimatedmay amountresult ofin thenta ornet necessaryincrease appropriationin is $0 for periods of imprisonment inor statecommitment. adult correctional facilities and $0 for periods of commitment to the custody of the Department of Juvenile Justice.

Pursuant to § 30-19.1:4 of the Code of Virginia, the estimated amount of the necessary appropriation is $0 for periods of imprisonment in state adult correctional facilities and $0 for periods of commitment to the custody of the Department of Juvenile Justice.